Mishra Saurabh, Taneja Sunil
Department of Gastroenterology and Hepatology, Paras Health, Sector 22, Panchkula, Haryana 134109, India.
Department of Hepatology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh 160012, India.
J Clin Exp Hepatol. 2024 May-Jun;14(3):101317. doi: 10.1016/j.jceh.2023.101317. Epub 2023 Dec 12.
Liver transplant (LT) recipients require close follow-up with regular monitoring of the liver function tests (LFTs). Evaluation of deranged LFT should be individualized depending upon the time since LT, peri-operative events, clinical course, and any complications. These derangements can range from mild and asymptomatic to severe and symptomatic elevations requiring expedited personalized assessment and management. Pattern of LFT derangement (hepatocellular, cholestatic, or mixed), donor-recipient risk factors, timing after LT (post-operative, 1-12 months, and >12 months since LT) along with clinical context and symptomatology are important considerations before proceeding with the initial evaluation. Compliance to immunosuppression and drug interactions should be ascertained along with local epidemiology of infections. Essential initial evaluation must include an ultrasound abdomen with Doppler to rule out any structural causes such as biliary or vascular complications apart from focussed laboratory evaluation. Early allograft dysfunction, ischemia reperfusion injury, small-for-size syndrome, biliary leaks, hepatic artery, and portal vein thrombosis are usual culprits in the early post-operative period whereas viral hepatitis (acute or reactivation), opportunistic infections, and recurrence of the primary disease are more frequent in the later period. Graft rejection, biliary strictures, sepsis, and drug induced liver injury remain possible etiologies at all times points after LT. Initial evaluation algorithm must be customized based on history, clinical examination, risk factors, and pattern and severity of deranged LFT. Allograft rejection is a diagnosis of exclusion and requires liver biopsy to confirm and assess severity. Empirical treatment of rejection sans liver biopsy is discouraged.
肝移植(LT)受者需要密切随访,并定期监测肝功能检查(LFTs)。对于肝功能检查结果异常的评估应根据肝移植后的时间、围手术期事件、临床病程以及任何并发症进行个体化。这些异常情况的范围可以从轻度无症状到严重有症状的升高,需要进行快速的个性化评估和管理。在进行初始评估之前,肝功能检查异常的模式(肝细胞性、胆汁淤积性或混合性)、供受者风险因素、肝移植后的时间(术后、1至12个月以及肝移植后超过12个月)以及临床背景和症状都是重要的考虑因素。应确定免疫抑制的依从性和药物相互作用,以及当地的感染流行病学情况。基本的初始评估必须包括腹部超声检查及多普勒检查,以排除任何结构性原因,如除了有针对性的实验室评估外的胆道或血管并发症。早期移植肝功能障碍、缺血再灌注损伤、小肝综合征、胆漏、肝动脉和门静脉血栓形成是术后早期常见的原因,而病毒肝炎(急性或再激活)、机会性感染和原发性疾病的复发在后期更为常见。移植排斥反应、胆道狭窄、败血症和药物性肝损伤在肝移植后的所有时间点都仍然是可能的病因。初始评估算法必须根据病史、临床检查、风险因素以及肝功能检查异常的模式和严重程度进行定制。移植排斥反应是一种排除性诊断,需要进行肝活检以确认并评估严重程度。不建议在没有肝活检的情况下对排斥反应进行经验性治疗。